Katharine Knobil

Insider Reports History

Entity
Individual
Location
C/O Kaleido Biosciences, Inc., 65 Hayden Ave., Lexington, MA
Signature
/s/ Ram Aiyar, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Katharine Knobil:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PLIANT THERAPEUTICS, INC. Director Common Stock (Right to Buy) 26.8K $55.7K $2.08 Jun 13, 2024 Direct
Korro Bio, Inc. Director Stock Option (Right to Buy) 9.04K Aug 26, 2024 Direct
Marker Therapeutics, Inc. Director Stock Option (right to buy) 8K Jun 6, 2023 Direct
ARENA PHARMACEUTICALS INC Director Common Stock 0 $98.51 Mar 11, 2022 Direct
ARENA PHARMACEUTICALS INC Director Stock Option (right to buy) 0 Mar 11, 2022 Direct

Insider Reports Filed by Katharine Knobil

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KRRO Korro Bio, Inc. Aug 26, 2024 1 $0 4 Aug 28, 2024 Director
KRRO Korro Bio, Inc. Aug 26, 2024 0 $0 3 Aug 28, 2024 Director
PLRX PLIANT THERAPEUTICS, INC. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
PLRX PLIANT THERAPEUTICS, INC. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
MRKR Marker Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
PLRX PLIANT THERAPEUTICS, INC. Sep 14, 2022 1 $0 4 Sep 16, 2022 Director
PLRX PLIANT THERAPEUTICS, INC. Sep 14, 2022 0 $0 3 Sep 16, 2022 Director
MRKR Marker Therapeutics, Inc. May 24, 2022 1 $0 4 May 26, 2022 Director
ARNA ARENA PHARMACEUTICALS INC Mar 11, 2022 5 $0 4 Mar 11, 2022 Director
MRKR Marker Therapeutics, Inc. Dec 8, 2021 1 $0 4 Dec 9, 2021 Director
MRKR Marker Therapeutics, Inc. Dec 8, 2021 0 $0 3 Dec 9, 2021 Director
ARNA ARENA PHARMACEUTICALS INC Jun 11, 2021 2 $0 4 Jun 15, 2021 Director